Buprenorphine vs Rituximab

## Buprenorphine vs Rituximab: Overview

This comparison examines the pharmacological differences between **Buprenorphine** and **Rituximab**.

## Mechanism of Action

**Buprenorphine**: Partial mu-opioid receptor agonist and kappa antagonist with high receptor affinity.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Buprenorphine — 24-42 hours; Rituximab — 22 days.

## Chemical Properties

**Molecular Formula**: Buprenorphine — C29H41NO4; Rituximab — N/A.

**Molecular Weight**: Buprenorphine — 467.6430 g/mol; Rituximab — N/A.

**Type**: Buprenorphine — Small molecule; Rituximab — Antibody.